A combination of five drugs will help overcome the drug stability of cancer cells
At the Oncology Center of the Medical University of South Carolina, the first phase of clinical tests of a complex of five drugs to combat chemotherapy with solid tumors in the later stages began . The drugs under consideration - hydroxychlorokhin, non -lfinavir, metformin, dazatinib and sylolymus - were developed for the treatment of malaria, HIV, diabetes of the second type, chronic myeloid leukemia, as well as to prevent organs from transplanted kidney from transplanted kidney.